Your browser doesn't support javascript.
loading
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant.
Chen, George; Herr, Megan; Nowak, Jan; Ho, Christine; Almyroudis, Nikolaos; Attwood, Kristopher; Bonnewell, John; Walsh, Marissa; Segal, Brahm; Ross, Maureen; McCarthy, Philip; Hahn, Theresa.
Afiliación
  • Chen G; Department of Medicine, Transplant and Cellular Therapy Program. George.chen@roswellpark.org.
  • Herr M; Department of Medicine, Transplant and Cellular Therapy Program.
  • Nowak J; Department of Pathology.
  • Ho C; Department of Medicine, Transplant and Cellular Therapy Program.
  • Almyroudis N; Department of Internal Medicine, Division of Infectious Diseases.
  • Attwood K; Department of Biostatistics.
  • Bonnewell J; Department of Internal Medicine, Division of Infectious Diseases.
  • Walsh M; Department of Internal Medicine, Division of Infectious Diseases.
  • Segal B; Department of Internal Medicine, Division of Infectious Diseases.
  • Ross M; Department of Medicine, Transplant and Cellular Therapy Program.
  • McCarthy P; Department of Medicine, Transplant and Cellular Therapy Program.
  • Hahn T; Department of Cancer Prevention and Control.
Haematologica ; 108(2): 615-620, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36263844

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article